IP Library Granted Patent US 10,975,406
Granted Patent B2
US 10,975,406 · App. 14/800,096 · Granted Apr 13, 2021

Directed endonucleases for repeatable nucleic acid cleavage

Inventors: Joseph M. Jacobson (Newton, MA); Noah Michael Jakimo (Boston, MA)
Assignee: Massachusetts Institute of Technology
C12P19/34C12N9/22C07K2319/00C07K2319/81C12N2310/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,975,406
App. No.
14/800,096
Granted
Apr 13, 2021
Kind
B2
Abstract

The invention provides compositions and methods for repeatable directed endonucleases (RDEs) and methods for repeatedly, and specifically cleaving DNA offset from the RDE's DNA recognition sequence on the target nucleic acid rather than within the DNA recognition sequence. Conservation of the recognition sequence of the target nucleic acid enables for re-localization of an RDE back to the DNA recognition sequence for further cleavage. The RDEs and methods of the invention are useful in applications including, but not limited to, recording data into a genome, timing the order of biochemical pathway events, efficient genome engineering and encoding lagged cellular death.

Claims (26)

1. A method for repeatedly cleaving a target nucleic acid in cells, cell lines, and transgenic organisms, comprising the following steps:

i) providing cells, cell lines, and transgenic organisms comprising:

a) one or more repeatable directed single-chain endonucleases (RDEs), wherein said RDE comprises a DNA-recognition domain that retains the ability to bind DNA but does not have, or has lost, an associated endonuclease activity that cleaves DNA at the DNA sequence bound at the site of said DNA-recognition domain of the RDE, and wherein the DNA-recognition domain of the RDE is fused to an active or inactive first nuclease domain via an amino acid linker, with said first nuclease domain further fused to a second active or inactive nuclease domain via a second amino acid linker attached to the C-terminus of the first nuclease domain; and

b) a target nucleic acid comprising one or more RDE recognition domains and one or more endogenous or synthetic essential or non-essential DNAs programmed for deletion;

ii) binding of the RDE to the target nucleic acid at a DNA sequence recognized by the DNA-recognition domain of the RDE;

iii) forming a dimer pair by said nuclease domains of the RDE on a DNA sequence that is not recognized by and is offset from the DNA-recognition domain of the RDE;

iv) single-stranded or double-stranded cleavage of the target nucleic acid at a site that is offset from the DNA sequence bound by said DNA-recognition domain of the RDE;

v) deletion of one or more base pairs at the site of cleavage, and repair of the DNA through endogenous repair and end joining processes; and

vi) repetition of steps ii) through v), wherein two or more relocalization events of the RDE cause additional removal of bases adjacent to the DNA-recognition domain.

2. The method of claim 1 , wherein the target nucleic acid comprises a promoter or gene for an essential element of the RDE; an RFP promoter or gene; a GFP promoter or gene; or an sgRNA promoter or gene.

3. The method of claim 2 , wherein the RDE comprises dCas9 linked to first FokI via a first linker and a second FokI linked to the first FokI via a second linker.

4. The method of claim 3 , wherein the first linker comprises at least 5 amino acid residues.

5. The method of claim 3 , wherein the second linker comprises at least 30 amino acid residues.

6. The method of claim 3 , wherein the first FokI and the second FokI form a dimer pair for cleaving the target nucleic acid.

7. The method of claim 2 , wherein the RDE comprises the DNA-recognition domain of a Zinc Finger protein, Transcription Activator Like Effector, or Cas9.

8. The method of claim 7 , wherein the DNA-recognition domain comprises dCas9 associated with a guide RNA.

9. The method of claim 2 , wherein the nuclease domain is selected from a homing endonuclease or a restriction enzyme.

10. The method of claim 9 , wherein the nuclease domain is selected from NucA, TevI, I-SceI, ColE7, FokI, PvuII, NdeI, BsrBI, BsaI, and MMeI.

11. The method of claim 1 , wherein the RDE comprises dCas9 linked to first FokI via a first linker and a second FokI linked to the first FokI via a second linker.

12. The method of claim 11 , wherein the first linker comprises at least 5 amino acid residues.

13. The method of claim 11 , wherein the second linker comprises at least 30 amino acid residues.

14. The method of claim 11 , wherein the first FokI and the second FokI form a dimer pair for cleaving the target nucleic acid.

15. The method of claim 1 , wherein the RDE comprises the DNA-recognition domain of a Zinc Finger protein, Transcription Activator Like Effector, or Cas9.

16. The method of claim 15 , wherein the DNA-recognition domain comprises dCas9 associated with a guide RNA.

17. The method of claim 1 , wherein the nuclease domain is selected from a homing endonuclease or a restriction enzyme.

18. The method of claim 17 , wherein the nuclease domain is selected from NucA, TevI, I-SceI, ColE7, FokI, PvuII, NdeI, BsrBI, BsaI, and MMeI.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2019
From: JACOBSON, JOSEPH M.; JAKIMO, NOAH MICHAEL
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 048687/0184 →
Continuity (2)
Provisional Application 62026577 · Jul 18, 2014
Related Publication 20160017393A1 · Jan 21, 2016